Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncol... von Agarwala, Sanjiv S, Lee, Sandra J, Yip, Waiki, Rao, Uma N, Tarhini, Ahmad A, Cohen, Gary I, Reintgen, Douglas S, Evans, Terry L, Brell, Joanna M, Albertini, Mark R, Atkins, Michael B, Dakhil, Shaker R, Conry, Robert M, Sosman, Jeffrey A, Flaherty, Lawrence E, Sondak, Vernon K, Carson, William E, Smylie, Michael G, Pappo, Alberto S, Kefford, Richard F, Kirkwood, John M

Volltext

A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma von Smylie, Michael G, Wong, Ralph, Mihalcioiu, Catalin, Lee, Chris, Pouliot, Jean-Francois

Volltext

Use of immuno-oncology in melanoma von Smylie, M G

Volltext

Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer von Mackey, John R., Tonkin, Katia S., Koski, Sheryl L., Scarfe, Andrew G., Smylie, Michael G.B., Joy, Anil A., Au, Heather-Jane, Bodnar, Dianne M., Soulieres, Denis, Smith, Stephanie W.

Volltext

Randomized controlled trial demonstrates novel tools to assess patient outcomes of Indigenous cultural safety training von Smylie, Janet, Rotondi, Michael A, Filipenko, Sam, Cox, William T L, Smylie, Diane, Ward, Cheryl, Klopfer, Kristina, Lofters, Aisha K, O'Neill, Braden, Graham, Melissa, Weber, Linda, Damji, Ali N, Devine, Patricia G, Collins, Jane, Hardy, Billie-Jo

Volltext

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma von Wolchok, Jedd D, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher D, Wagstaff, John, Schadendorf, Dirk, Ferrucci, Pier F, Smylie, Michael, Dummer, Reinhard, Hill, Andrew, Hogg, David, Haanen, John, Carlino, Matteo S, Bechter, Oliver, Maio, Michele, Marquez-Rodas, Ivan, Guidoboni, Massimo, McArthur, Grant, Lebbé, Celeste, Ascierto, Paolo A, Long, Georgina V, Cebon, Jonathan, Sosman, Jeffrey, Postow, Michael A, Callahan, Margaret K, Walker, Dana, Rollin, Linda, Bhore, Rafia, Hodi, F. Stephen, Larkin, James

Volltext

Comprehensive in vitro characterization of PD-L1 small molecule inhibitors von Ganesan, Aravindhan, Ahmed, Marawan, Okoye, Isobel, Arutyunova, Elena, Babu, Dinesh, Turnbull, William L., Kundu, Joydeb Kumar, Shields, Justin, Agopsowicz, Katharine Cheryl, Xu, Lai, Tabana, Yasser, Srivastava, Nutan, Zhang, Guangzhi, Moon, Tae Chul, Belovodskiy, Alexandr, Hena, Mostofa, Kandadai, Appan Srinivas, Hosseini, Seyedeh Nargess, Hitt, Mary, Walker, John, Smylie, Michael, West, Frederick G., Siraki, Arno G., Lemieux, M. Joanne, Elahi, Shokrollah, Nieman, James A., Tyrrell, D. Lorne, Houghton, Michael, Barakat, Khaled

Volltext

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma von Larkin, James, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean Jacques, Cowey, C. Lance, Lao, Christopher D, Schadendorf, Dirk, Dummer, Reinhard, Smylie, Michael, Rutkowski, Piotr, Ferrucci, Pier F, Hill, Andrew, Wagstaff, John, Carlino, Matteo S, Haanen, John B, Maio, Michele, Marquez-Rodas, Ivan, McArthur, Grant A, Ascierto, Paolo A, Long, Georgina V, Callahan, Margaret K, Postow, Michael A, Grossmann, Kenneth, Sznol, Mario, Dreno, Brigitte, Bastholt, Lars, Yang, Arvin, Rollin, Linda M, Horak, Christine, Hodi, F. Stephen, Wolchok, Jedd D

Volltext

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer von Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O’Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leiby, Melanie A, Lubiniecki, Gregory M, Shentu, Yue, Rangwala, Reshma, Brahmer, Julie R

Volltext

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma von Wolchok, Jedd D, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D, Cowey, C Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Butler, Marcus O, Hill, Andrew, Márquez-Rodas, Ivan, Haanen, John B A G, Guidoboni, Massimo, Maio, Michele, Schöffski, Patrick, Carlino, Matteo S, Lebbé, Céleste, McArthur, Grant, Ascierto, Paolo A, Daniels, Gregory A, Long, Georgina V, Bas, Tuba, Ritchings, Corey, Larkin, James, Hodi, F Stephen

Volltext

Anti‐PD1‐Induced Immune‐Related Adverse Events and Survival Outcomes in Advanced Melanoma von Suo, Aleksi, Chan, Yin, Beaulieu, Carissa, Kong, Shiying, Cheung, Winson Y., Monzon, Jose G., Smylie, Michael, Walker, John, Morris, Don, Cheng, Tina

Volltext

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer von Shepherd, Frances A, Rodrigues Pereira, José, Ciuleanu, Tudor, Tan, Eng Huat, Hirsh, Vera, Thongprasert, Sumitra, Campos, Daniel, Maoleekoonpiroj, Savitree, Smylie, Michael, Martins, Renato, van Kooten, Maximiliano, Dediu, Mircea, Findlay, Brian, Tu, Dongsheng, Johnston, Dianne, Bezjak, Andrea, Clark, Gary, Santabárbara, Pedro, Seymour, Lesley

Volltext

A phase 2 study of tremelimumab in patients with advanced uveal melanoma von Joshua, Anthony M, Monzon, Jose G, Mihalcioiu, Catalin, Hogg, David, Smylie, Michael, Cheng, Tina

Volltext

Genome-Wide Single-Nucleotide Polymorphism Analysis Defines Haplotype Patterns in Mouse von Wiltshire, Tim, Pletcher, Mathew T., Batalov, Serge, Barnes, S. Whitney, Tarantino, Lisa M., Cooke, Michael P., Wu, Hua, Smylie, Kevin, Santrosyan, Andrey, Copeland, Neal G., Jenkins, Nancy A., Kalush, Francis, Mural, Richard J., Glynne, Richard J., Kay, Steve A., Adams, Mark D., Fletcher, Colin F.

Volltext

Patterns and predictors of relapse in Merkel cell carcinoma: Results from a population-based study von Joseph, Kurian, Wong, Justina, Abraham, Aswin, Zebak, Julia, Patel, Anushree, Jones Thachuthara, Aoife, Iqbal, Umar, Pham, Truong-Minh, Menon, Anjali, Ghosh, Sunita, Warkentin, Heather, Walker, John, Jha, Naresh, Faruqi, Salman, Salopek, Thomas G., Smylie, Michael

Volltext

Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067 von Hodi, F. Stephen, Chiarion -Sileni, Vanna, Lewis, Karl D., Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D., Cowey, Charles Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Queirolo, Paola, Smylie, Michael, Butler, Marcus O., Hill, Andrew Graham, Marquez-Rodas, Ivan, Haanen, John B. A. G., Durani, Piyush, Wang, Peter, Wolchok, Jedd D., Larkin, James

Volltext

CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma von Wolchok, Jedd D., Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D., Cowey, Charles Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Butler, Marcus O., Hill, Andrew Graham, Marquez-Rodas, Ivan, Haanen, John B. A. G., Bas, Tuba, van Dijck, Wim, Larkin, James, Hodi, F. Stephen

Volltext

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma von Wolchok, Jedd D, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D, Cowey, C Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Butler, Marcus O, Hill, Andrew, Márquez-Rodas, Ivan, Haanen, John B A G, Guidoboni, Massimo, Maio, Michele, Schöffski, Patrick, Carlino, Matteo S, Lebbé, Céleste, McArthur, Grant, Ascierto, Paolo A, Daniels, Gregory A, Long, Georgina V, Bas, Tuba, Ritchings, Corey, Larkin, James, Hodi, F Stephen

Volltext

CheckMate 067: Long-term outcomes in patients with mucosal melanoma von Shoushtari, Alexander Noor, Wagstaff, John, Ascierto, Paolo Antonio, Butler, Marcus O., Lao, Christopher D., Marquez-Rodas, Ivan, Chiarion-Sileni, Vanna, Dummer, Reinhard, Ferrucci, Pier F., Lorigan, Paul, Smylie, Michael, van Dijck, Wim, Rizzo, Jasmine I., Hodi, F. Stephen, Larkin, James M. G.

Volltext